Sevelamer for Reducing Endotoxemia and Immune Activation
Clinical trial NCT01543958 · COMPLETED
Trial details
- NCT number
- NCT01543958
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.